Administration of thrombolytic therapy to 17,944 patients with acute myocardial infarction: The GISSI-3 database

American Heart Journal

Volumn 135, Issue 3, 1998, Pages 443-448

  Bobbio, M ^a   Bergerone, S ^a   Maggioni, A P ^a   Malacrida, R ^a   Franzosi, M G ^a   Barlera, S ^a   Tognoni, G ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT; GLYCEROL NITRATE; LISINOPRIL;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031917739     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(98)70320-5     Document Type: Article

References (27)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico GISSI Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Lancet 1 1986 397 402
2. ISIS-2 Second international Study on Infarct Survival Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 Lancet 2 1988 349 360
3. ACC/AHA Task Force Guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures J Am Coll Cardiol 16 1990 249 292
4. Task Force on the Management of Acute Myocardial infarction of the European Society of Cardiology Acute myocardial infarction: pre-hospital and in-hospital management Eur Heart J 17 1996 43 63
5. Fibrinolytic Therapy Trialists' FTT Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results form all randomised trials of more than 1000 patients Lancet 343 1994 311 322
6. EM Antman J Lau B Kupelnik F Mosteller TC. Chalmers A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: treatments for myocardial infarction JAMA 268 1992 240 248
7. C Pashos SLT Normand JB Garfinkle Newhouse AM Epstein BJ. McNeil Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992 J Am Coll Cardiol 23 1994 1023 1030
8. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction Lancet 343 1994 1115 1122
9. SJ Bernstein M Laouri LH Hilborne Coronary angiography: a literature review and ratings of appropriateness and necessity 1992 RAND Corporation Santa Monica, Calif 47
10. DWM Muller EJ. Topol Selection of patient with acute myocardial infarction for thrombolytic therapy Ann Intern Med 113 1990 949 960
11. R Althouse C Maynard MD Cerqueira M Olsufka JL Ritchie JW. Kennedy The Western Washington Myocardial Infarction Registry and Emergency Department Tissue Plasminogen Activator Treatment Trial Am J Cardiol 66 1990 1298 1303
12. AJ Doorey EL Michelson FJ Weber LS. Dreifus Thrombolytic therapy of acute myocardial infarction: emerging challenges of implementation J Am Coll Cardiol 10 1987 1357 1360
13. CL Grines AN. De Maria Optimal utilization of thrombolytic therapy for acute myocardial infarction: concept and controversies J Am Coll Cardiol 16 1990 223 231
14. L Pilote N Racine MA. Hlatky Differences in the treatment of myocardial infarction in the United States and Canada Arch Intern Med 154 1994 1090 1096
15. DR Cragg HZ Friedman JD Bonema Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy Ann Intern Med 115 1991 173 177
16. ISIS-4 Fourth International Study in Infarct Survival Collaborative Group ISIS-4 A randomised factorial trial assessing early oral captopril, oral monitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction Lancet 345 1995 669 685
17. JD Jagger RG Murray MK Davies WA Littler EJ. Flint Eligibility for thrombolytic therapy in acute myocardial infarction Lancet 1 1987 34 35
18. AJ Doorey EL Michelson EJ. Topol Thrombolytic therapy of acute myocardial infarction: keeping the unfulfilled promises JAMA 268 1992 3108 3114
19. S Yusuf P Sleight P Held S. McMahon Routine medical management of acute myocardial infarction: lessons form overviews of recent randomized controlled trials Circulation 82 suppl II 1990 II-117 II-34
20. JL Rouleau LA Moye MA Pfeffer A comparison of management patterns after acute myocardial infarction in Canada and the United States N Engl J Med 328 1993 779 784
21. KM Hussain L Gould B Sosler T Bharathan CV. Reddy Clinical science review: current aspects of thrombolytic therapy in women with acute myocardial infarction Angiology 47 1996 23 33
22. TJ McLaughlin SB Soumerai DJ Willison Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly Arch Intern Med 156 1996 799 805
23. J. Blustein High-technology cardiac procedures: the impact of service availability on service use in New York State JAMA 270 1993 344 349
24. NR Every EB Larson PE Litwin The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute mocardial infarction N Engl J Med 329 1993 546 551
25. WJ Rogers LJ Bowlby NC Chandra Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction Circulation 90 1994 2103 2114
26. HS Lee SJ Cross JM Rawles KP. Jennings Patients with suspected myocardial infarction who present with ST depression Lancet 342 1993 1204 1207
27. The TIMI IIIB Investigators Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-q-wave myocardial infarction: results of the TIMI IIIB trial Circulation 89 1994 1545 1556